Skip to content
1887

Abstract

Foamy viruses (FVs) are complex retroviruses which require for their replication the activity of a transcriptional trans-activator (Tas) as well as Tas-responsive elements in the viral promoters. A mutant of the chimpanzee FV strain, CFV/hu (previously called human FV), genome in which most of the U3 promoter of the CFV long terminal repeat was substituted by the constitutively active human cytomegalovirus immediate early gene enhancer/promoter was constructed. This plasmid (pTS12) and a derivative (pTS13), which has a deletion in the tas gene, gave rise to replication-competent virus. Compared with parental CFV, both mutants replicated only very poorly, with retarded growth kinetics and maximal cell-free virus titres reduced by approximately three orders of magnitude. Mutation of the DD35E motif of the CFV integrase to DA35E rendered the recombinant TS virus replication-deficient. This indicated that provirus integration is probably still required for this FV derivative, which had been converted from a complex regulated retrovirus into a simple one by incorporation of a constitutively active promoter from another virus which regularly does not integrate into the host cell genome.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-7-1591
1999-07-01
2025-05-12
Loading full text...

Full text loading...

References

  1. Ausubel F. M., Brent R., Kingston R. E., Moore D., Seidman J. G., Smith J. A., Struhl K. 1987 Current Protocols in Molecular Biology New York: John Wiley;
    [Google Scholar]
  2. Baum C., Ito K., Meyer J., Laker C., Ito Y., Ostertag W. 1997; The potent enhancer activity of the polycythemic strain of spleen focusforming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. Journal of Virology 71:6323–6331
    [Google Scholar]
  3. Baunach G., Maurer B., Hahn H., Kranz M., Rethwilm A. 1993; Functional analysis of human foamy virus accessory reading frames. Journal of Virology 67:5411–5418
    [Google Scholar]
  4. Boris-Lawrie K., Temin H. M. 1995; Genetically simpler bovine leukemia virus derivatives can replicate independently of tax and rex. Journal of Virology 69:1920–1924
    [Google Scholar]
  5. Boris-Lawrie K., Altarenova V., Altaner C., Kucerova L., Temin H. M. 1997; In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex. Journal of Virology 71:1514–1520
    [Google Scholar]
  6. Boshart M., Weber F., Jahn G., Dorsch-Hasler K., Fleckenstein B., Schaffner W. 1985; A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521–530
    [Google Scholar]
  7. Brown P. O. 1997; Integration. In Retroviruses pp 161–203 Edited by Coffin J. M. Hughes S. H., Varmus H. E. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;
    [Google Scholar]
  8. Cullen B. R. 1991; Human immunodeficiency virus as a prototypic complex retrovirus. Journal of Virology 65:1053–1056
    [Google Scholar]
  9. DuBridge R. B., Tang P., Hsia H. C., Leong P.-M., Miller J. H., Calos M. P. 1987; Analysis of mutation in human cells by using Epstein–Barr virus shuttle system. Molecular and Cellular Biology 7:379–387
    [Google Scholar]
  10. Enssle J., Moebes A., Heinkelein M., Panhuysen M., Mauer B., Schweizer M., Neumann-Haefelin D., Rethwilm A. 1999; An active human foamy virus integrase is required for virus replication. Journal of General Virology 80:1445–1452
    [Google Scholar]
  11. Erlwein O., Rethwilm A. 1993; BEL-1 transactivator responsive sequences in the long terminal repeat of human foamy virus. Virology 196:256–268
    [Google Scholar]
  12. Hahn H., Baunach G., Bräutigam S., Mergia A., Neumann-Haefelin D., Daniel M. D., McClure M. O., Rethwilm A. 1994; Reactivity of primate sera to foamy virus Gag and Bet proteins. Journal of General Virology 75:2635–2644
    [Google Scholar]
  13. He F., Blair W. S., Fukushima J., Cullen B. R. 1996; The human foamy virus bel-1 transcriptional factor is a sequence-specific DNA binding protein. Journal of Virology 70:3902–3908
    [Google Scholar]
  14. Heinkelein M., Schmidt M., Fischer N., Moebes A., Lindemann D., Enssle J., Rethwilm A. 1998; Characterization of a cis-acting sequence in the pol region required to transfer human foamy virus vectors. Journal of Virology 72:6307–6314
    [Google Scholar]
  15. Hornung M., Lindemann D., Kraus C., Peters A., Berberich I. 1998; The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IgM-induced growth arrest. European Journal of Immunology 28:3812–3823
    [Google Scholar]
  16. Keller A., Partin K. M., Löchelt M., Bannert H., Flügel R. M., Cullen B.R. 1991; Characterization of the transcriptional trans activator of human foamy retrovirus. Journal of Virology 65:2589–2594
    [Google Scholar]
  17. Kögel D., Aboud M., Flugel R. M. 1995; Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology 213:97–108
    [Google Scholar]
  18. Lee K. I., Lee A. H., Sung Y. C. 1993; Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. Journal of Virology 67:2317–2326
    [Google Scholar]
  19. Lindemann D., Rethwilm A. 1998; Characterization of a human foamy virus 170 kD env–bet fusion protein generated by alternative splicing. Journal of Virology 72:4088–4094
    [Google Scholar]
  20. Linial M. L. 1999; Foamy viruses are nonconventional retroviruses. Journal of Virology 73:1747–1755
    [Google Scholar]
  21. Löchelt M., Muranyi W., Flugel R. M. 1993; Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proceedings of the National Academy of Sciences, USA 90:7317–7321
    [Google Scholar]
  22. Löchelt M., Flugel R. M., Aboud M. 1994; The human foamy virus internal promoter directs the expression of the functional bel 1 transactivator and bet protein early after infection. Journal of Virology 68:638–645
    [Google Scholar]
  23. Löchelt M., Yu S., Linial M., Flugel R. M. 1995; The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology 206:601–610
    [Google Scholar]
  24. Mocarski E. S. 1996; Cytomegaloviruses and their replication. In Fields Virology 3rd edn, pp 2447–2492 Edited by Fields B. N. Knipe D. M., Howley P. M. New York: Lippincott-Raven;
    [Google Scholar]
  25. Moebes A., Enssle J., Bieniasz P. D., Heinkelein M., Lindemann D., Bock M., McClure M. O., Rethwilm A. 1997; Human foamy virus reverse transcription that occurs late in the viral replication cycle. Journal of Virology 71:7305–7311
    [Google Scholar]
  26. Namba M., Nishitani K., Hyodoh F., Fukushima F., Kimoto T. 1985; Neoplastic transformation of human diploid fibroblasts (KMST-6) by treatment with 60Co gamma rays. International Journal of Cancer 35:275–280
    [Google Scholar]
  27. Pietschmann T., Heinkelein M., Zentgraf H., Rethwilm A., Lindemann D. 1999; Foamy virus capsids require the cognate envelope protein for particle export. Journal of Virology 73:2613–2621
    [Google Scholar]
  28. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–497
    [Google Scholar]
  29. Rethwilm A. 1995; Regulation offoamy virus gene expression. Current Topics in Microbiology and Immunology 193:1–23
    [Google Scholar]
  30. Rethwilm A. 1996; Unexpected replication pathways offoamy viruses. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13: (Suppl 1) S248–S253
    [Google Scholar]
  31. Rethwilm A., Mori K., Maurer B., ter Meulen V. 1990; Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology 175:568–571
    [Google Scholar]
  32. Rethwilm A., Erlwein O., Baunach G., Maurer B., ter Meulen V. 1991; The transcriptional transactivator of human foamy virus maps to the bel1 genomic region. Proceedings of the National Academy of Sciences, USA 88:941–945
    [Google Scholar]
  33. Schliephake A. W., Rethwilm A. 1994; Nuclear localization of foamy virus gag precursor protein. Journal of Virology 68:4946–4954
    [Google Scholar]
  34. Schmidt M., Rethwilm A. 1995; Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 210:167–178
    [Google Scholar]
  35. Schmidt M., Herchenröder O., Heeney J., Rethwilm A. 1997; Long terminal repeat U3 length polymorphism of human foamy virus. Virology 230:167–178
    [Google Scholar]
  36. Temin H. M. 1993; A proposal for a new approach to a preventive vaccine against human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 90:4419–4420
    [Google Scholar]
  37. Venkatesh L. K., Chinnadurai G. 1993; The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. Journal of Virology 67:3868–3876
    [Google Scholar]
  38. Weiss R. A. 1996; Foamy viruses bubble on. Nature 380:201
    [Google Scholar]
  39. Yu S. F., Linial M. L. 1993; Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. Journal of Virology 67:6618–6624
    [Google Scholar]
  40. Yu S. F., Baldwin D. N., Gwynn S. R., Yendapalli S., Linial M. L. 1996; Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271:1579–1582
    [Google Scholar]
  41. Yu S. F., Sullivan M. D., Linial M. L. 1999; Evidence that the human foamy virus genome is DNA. Journal of Virology 73:1565–1572
    [Google Scholar]
  42. Zou J. X., Luciw P. A. 1996; The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proceedings of the National Academy of Sciences, USA 93326–330
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-80-7-1591
Loading
/content/journal/jgv/10.1099/0022-1317-80-7-1591
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error